ANOCCA (IEU TI)
Sector: Manufacturing (Industrial) • Location: Sweden
Source: European Investment Bank (EIB)
The Promoter-s technologies enable highly precise and efficient analysis of T-cell immunity required to deliver a range of therapeutics and vaccines that specifically harness or manipulate T-cell immunity. With a focus on delivering T-cell receptor modified T-cell therapies (TCR-T) in oncology, the Promoter is rapidly progressing a pipeline of novel therapies towards clinical trials utilizing its
- Status
- Prospective
- Sector
- Manufacturing (Industrial), Government
- Location
- Sweden
- Updated
- 19 Nov 2026
- Source
- European Investment Bank (EIB)
ConstructChat
Ask ConstructChat about ANOCCA (IEU TI)
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | partially disbursed |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | The Promoter-s technologies enable highly precise and efficient analysis of T-cell immunity required to deliver a range of therapeutics and vaccines that specifically harness or manipulate T-cell immunity. With a focus on delivering T-cell receptor modified T-cell therapies (TCR-T) in oncology, the Promoter is rapidly progressing a pipeline of novel therapies towards clinical trials utilizing its own manufacturing capabilities. Promoter's breakthrough technology has high market potential to addr |
Original sector | Services |
Location
Country | Sweden |
Source
Source | European Investment Bank (EIB) |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial), Government |
Article published date | 2025-08-01 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
